Hepatocyte growth factor (HGF)/transforming growth factor (TGF-beta1) balance in renal biopsies and clinical outcome in patients with lupus nephritis treated with cyclophosphamide

被引:0
|
作者
Peluso, G
Capuano, A
Costanzi, S
Zannoni, G
Vellone, VG
Gremese, E
Zoli, A
Ferraccioli, G
机构
[1] Univ Cattolica Sacro Cuore, Dept Rheumatol, Rome, Italy
[2] Univ Cattolica Sacro Cuore, Dept Nephrol, Rome, Italy
[3] Univ Cattolica Sacro Cuore, Inst Pathol, Rome, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:242 / 242
页数:1
相关论文
共 50 条
  • [1] Balance between hepatocyte growth factor (HGF) and transforming growth factor (TGF-beta1) in renal biopsies of patients with lupus nephritis
    Capuano, A
    Peluso, G
    Costanzi, S
    Zannoni, G
    Vellone, VG
    Scott, C
    Romano, G
    Gremese, E
    Zoli, A
    Ferraccioli, G
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 242 - 242
  • [2] Hepatocyte growth factor (HGF) and transforming growth factor (TGF-β1) expression in 42 renal biopsy from lupus nephritis patients.: Role of the HGF/TGFB1 ratio as a prognostic factor
    Zannoni, Gianfranco
    Arena, Vincenzo
    Gremese, Etisa
    Costanzi, Stefano
    Capelli, Arnaldo
    Ferraccioli, Gianfranco
    VIRCHOWS ARCHIV, 2008, 452 : S270 - S270
  • [3] Hepatocyte growth factor and transforming growth factor β1 ratio at baseline can predict early response to cyclophosphamide in systemic lupus erythematosus nephritis
    Capuano, Anna
    Costanzi, Stefano
    Peluso, Giusy
    Zannoni, Gianfranco
    Vellone, Valerio Gaetano
    Gremese, Elisa
    Zoli, Angelo
    Scott, Cathryn
    Beltrami, Carlo Alberto
    Romano, Giulio
    Ferraccioli, Gianfranco
    ARTHRITIS AND RHEUMATISM, 2006, 54 (11): : 3633 - 3639
  • [4] Reciprocal balance of hepatocyte growth factor and transforming growth factor-β1 in renal fibrosis in mice
    Mizuno, S
    Matsumoto, K
    Kurosawa, T
    Mizuno-Horikawa, Y
    Nakamura, T
    KIDNEY INTERNATIONAL, 2000, 57 (03) : 937 - 948
  • [5] Assessment of plasma and urinary transforming growth factor beta 1 (TGF-beta 1) in children with lupus nephritis
    Salam, Sanaa M. Abdel
    Saleh, Safaa H. A.
    El-Shahawy, Eman E.
    Moety, Hanaa Abdel
    EGYPTIAN JOURNAL OF PEDIATRIC ALLERGY AND IMMUNOLOGY, 2011, 9 (01): : 21 - 27
  • [6] Increased Serum Transforming Growth Factor-beta1 (Tgf-beta1) Is Related to a Better Outcome in MM, WM and CLL Patients
    Maltezas, Dimitrios
    Sarris, Katerina
    Koulieris, Efstathios
    Tzenou, Tatiana
    Bartzis, Vassiliki
    Nikolaou, Eftychia
    Gavriatopoulou, Maria
    Dimou, Maria
    Terpos, Evangelos
    Angelopoulou, Maria K.
    Vassilakopoulos, Theodoros P.
    Panayiotidis, Panayiotis
    Pangalis, Gerasimos
    Dimopoulos, Meletios A.
    Kyrtsonis, Marie-Christine
    BLOOD, 2012, 120 (21)
  • [7] Serum levels of growth factors HGF (Hepatocyte Growth Factor), TGFβ1 (transforming growth factor β1) and IGF-I (Insulin Like Growth Factor I) in parathyroid tumors
    Astl, J
    Vesely, D
    Matucha, P
    Martínek, J
    Kucera, T
    Lastuvka, P
    Betka, J
    Sterzl, I
    NEUROENDOCRINOLOGY LETTERS, 2004, 25 (05) : 356 - 360
  • [8] Transforming growth factor beta 1 in children with systemic lupus erythematosus: a possible relation with clinical presentation of lupus nephritis
    Hammad, A. M.
    Youssef, H. M.
    El-Arman, M. M.
    LUPUS, 2006, 15 (09) : 608 - 612
  • [9] Hepatocyte growth factor and transforming growth factor-β1 balance in experimental diabetic nephropathy
    Cruzado, JM
    Lloberas, N
    Torras, J
    Riera, M
    Fillat, C
    Herrero, D
    Aran, JM
    Castelao, AM
    Grinyo, JM
    DIABETES, 2002, 51 : A181 - A181
  • [10] Transforming growth factor (TGF) beta pathway and clinical outcome of pancreatic cancer.
    Javle, Milind M.
    Tan, Dongfeng
    Li, Yanan
    Kar, Siddhartha P.
    Baladandayuthapani, Veera
    Dong, Xiaoqun
    Weatherly, Jacqueline
    Krishnan, Sunil
    Huang, Tzu-chuan Jane
    Fogelman, David R.
    Abbruzzese, James L.
    Wolff, Robert A.
    Li, Donghui
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)